FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry

A consortium of academics, manufacturers and government agencies plans to launch a national atrial fibrillation ablation registry, based on input from a variety of stakeholders at a meeting April 27 and 28 at FDA's White Oak, Md., headquarters

More from Archive

More from Medtech Insight